Symcel
Spånga
About Symcel
Symcel provides a novel cellbased assay tool for real time cellular bioenergetic measurements. Symcel develops and markets analytical instrumentations that fulfill an unmet need for cell biological research and development, within R&D departments of Life Science industry, as well as academic research laboratories. Our solution is a fast label-free assay technology providing real-time continuous data monitoring of cell metabolism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Last round: Grant (Nov 2017)
- Website: symcel.com
- Phone: [email protected]
Industries & Categories
Analytics, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/symcel-42169 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.